Gradual resumption in Aeson implantations in line with progressive production ramp-up over the year 2023 Cash position of €51 million as of December 31, 2022 and active exploration of financing
Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of Aeson®, the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering